Expert Rev Neurother

• 

  Publication Venue For

  • Advances in autoimmune myasthenia gravis management..  18:573-588. 2018
  • How should we treat post-traumatic stress disorder in active military personnel?.  17:641-643. 2017
  • The role of neuroendocrine pathways in prognosis after stroke..  14:217-232. 2014
  • Melanoma brain metastasis: overview of current management and emerging targeted therapies..  12:1207-1215. 2012
  • Molecular PET imaging in multicenter Alzheimer's therapeutic trials: current trends and implementation strategies..  11:1783-1793. 2011
  • Physical activity and the risk of stroke..  10:1263-1265. 2010
  • Clinical application of blood biomarkers in cerebrovascular disease..  10:189-203. 2010
  • B-lymphocyte depletion for the treatment of multiple sclerosis: now things really get interesting..  9:309-312. 2009
  • Functional MRI in the early diagnosis of Alzheimer's disease: is it time to refocus?.  8:169-175. 2008
  • Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion..  7:1251-1263. 2007
  • Long-acting injectable naltrexone for the treatment of alcohol dependence..  7:1265-1277. 2007
  • Viruses in the treatment of malignant glioma..  7:321-324. 2007
  • Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder..  5:587-595. 2005
  • Aripiprazole: pharmacology, efficacy, safety and tolerability..  5:297-307. 2005
  • Treating brain metastases: current approaches and future directions..  4:1015-1022. 2004
  • Provisional diagnostic criteria for depression of Alzheimer's disease: description and review..  3:99-106. 2003
  • Treatment of myasthenia gravis: current practice and future directions..  2:743-748. 2002
  • Behavioral treatment of insomnia..  2:127-137. 2002